Grifols SA Financials

GRFS Stock  USD 8.12  0.02  0.25%   
Based on the key measurements obtained from Grifols SA's financial statements, Grifols SA ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At this time, Grifols SA's Non Current Assets Total are comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 819.2 M in 2025, whereas Retained Earnings are likely to drop slightly above 64.8 M in 2025. Key indicators impacting Grifols SA's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.02070.0218
Notably Down
Slightly volatile
Return On Assets0.0070.0073
Notably Down
Slightly volatile
Return On Equity0.02530.0267
Notably Down
Slightly volatile
Debt Equity Ratio1.771.7193
Fairly Up
Slightly volatile
Operating Income675.4 M848.6 M
Significantly Down
Slightly volatile
Current Ratio2.092.6564
Significantly Down
Pretty Stable
The financial analysis of Grifols SA is a critical element in measuring its lifeblood. Investors should not minimize Grifols SA's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

64.8 Million

  
Understanding current and past Grifols SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Grifols SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Grifols SA's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Grifols SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Grifols SA ADR. Check Grifols SA's Beneish M Score to see the likelihood of Grifols SA's management manipulating its earnings.

Grifols SA Stock Summary

Grifols SA competes with Novartis, AstraZeneca PLC, GlaxoSmithKline PLC, Roche Holding, and Bristol Myers. Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS3984384087
CUSIP398438408 398438309 398438200
LocationNew York; U.S.A
Business AddressAvinguda de la
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.grifols.com
Phone34 935 712 200
CurrencyUSD - US Dollar

Grifols SA Key Financial Ratios

Grifols SA Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets15.3B19.2B21.5B21.4B24.7B25.9B
Other Current Liab361.8M382.8M470.0M550.9M633.5M665.2M
Net Debt6.3B8.7B9.2B9.6B11.0B11.6B
Retained Earnings618.5M182.8M208.3M59.3M68.2M64.8M
Accounts Payable601.6M629.0M731.9M813.1M935.1M981.8M
Cash579.6M655.5M548.0M529.6M609.0M588.5M
Net Receivables504.2M495.5M754.8M811.0M932.6M474.0M
Good Will5.3B6.2B7.0B6.8B7.8B8.2B
Inventory2.0B2.3B3.2B3.5B4.0B4.2B
Other Current Assets78.8M2.1B149.4M1.5B1.8B1.9B
Total Liab8.6B11.1B13.1B13.5B15.5B16.3B
Total Current Assets3.2B5.5B4.7B6.5B7.4B7.8B
Short Term Debt319.6M2.4B681.3M897.9M1.0B1.1B
Intangible Assets1.6B1.6B2.9B2.8B3.3B3.4B
Other Liab544.2M617.5M682.4M2.1B2.4B2.5B
Other Assets149.9M882.6M1.9B(13.6M)(15.7M)(14.9M)
Long Term Debt5.9B6.1B8.2B8.2B9.4B5.4B
Net Tangible Assets(1.8B)(2.5B)(1.1B)(2.2B)(2.0B)(2.1B)
Short Long Term Debt276.9M2.3B578.9M790.8M711.7M578.3M

Grifols SA Key Income Statement Accounts

The reason investors look at the income statement is to determine what Grifols SA's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Expense222.9M233.8M362.6M596.9M686.4M720.7M
Total Revenue5.3B4.9B6.1B6.6B7.6B8.0B
Gross Profit2.3B2.0B2.2B2.3B2.7B1.6B
Operating Income996.1M595.1M805.7M737.9M848.6M675.4M
Ebit1.0B562.7M755.8M740.1M851.1M721.7M
Ebitda1.4B922.5M1.2B1.2B1.4B864.5M
Cost Of Revenue3.1B3.0B3.8B4.3B4.9B5.2B
Income Before Tax878.6M350.5M361.3M224.0M257.6M450.0M
Net Income618.5M265.3M208.3M59.3M68.2M64.8M
Income Tax Expense169.6M85.1M90.1M43.3M49.9M98.9M
Research Development294.2M354.9M361.1M330.6M380.1M234.3M
Minority Interest1.6B(82.5M)(62.9M)(114.9M)(132.1M)(125.5M)
Tax Provision169.6M85.1M90.1M27.2M24.5M23.3M
Net Interest Income(241.6M)(266.4M)(462.7M)(574.1M)(516.7M)(490.9M)
Interest Income8.0M11.6M33.9M62.3M71.7M36.2M

Grifols SA Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory164.6M(157.5M)(600.2M)(427.1M)(384.4M)(365.2M)
Change In Cash(162.3M)2.1B(2.1B)(18.4M)(16.6M)(15.7M)
Free Cash Flow747.8M281.9M(386.4M)(87.1M)(100.2M)(95.2M)
Depreciation321.5M359.8M407.9M441.9M508.2M533.6M
Other Non Cash Items(196.1M)27.7M(170.8M)76.7M69.0M72.4M
Dividends Paid278.8M238.7M113.2M258.9M592K0.0
Capital Expenditures362.6M315.1M375.6M295.4M339.7M246.6M
Net Income878.6M350.5M361.3M59.3M68.2M64.8M
End Period Cash Flow579.6M2.7B548.0M529.6M609.0M705.5M
Investments(858.1M)9.8M(2.0B)(397.6M)(357.9M)(375.8M)
Net Borrowings(7.5M)(243.4M)1.9B(177.4M)(204.0M)(193.8M)
Change To Netincome122.9M11.7M195.3M(17.8M)(16.0M)(15.2M)

Grifols Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.
Grifols SA ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  1.06  of Return On Asset per Return On Equity. At this time, Grifols SA's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Grifols SA by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Grifols SA ADR Systematic Risk

Grifols SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Grifols SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Grifols SA ADR correlated with the market. If Beta is less than 0 Grifols SA generally moves in the opposite direction as compared to the market. If Grifols SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Grifols SA ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Grifols SA is generally in the same direction as the market. If Beta > 1 Grifols SA moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Grifols SA Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Grifols SA's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Grifols SA growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.24

At this time, Grifols SA's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

Grifols SA March 20, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Grifols SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Grifols SA ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Grifols SA ADR based on widely used predictive technical indicators. In general, we focus on analyzing Grifols Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Grifols SA's daily price indicators and compare them against related drivers.

Additional Tools for Grifols Stock Analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.